Diagnostic Accuracy Of Seismocardiography for Coronary Artery Disease
Launched by HEART FORCE MEDICAL INC. · Mar 14, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 years or older.
- • Suspected CAD, based on clinical evaluation.
- • Able to provide informed consent.
- Exclusion Criteria:
- • Pregnant or breastfeeding women.
- • Presence of implanted cardiac devices (e.g., pacemakers, implantable cardioverter defibrillators) that may interfere with SCG/GCG signal acquisition.
- • Severe arrhythmias that may affect signal interpretation.
- • Inability to maintain required testing positions (supine and sitting).
- • Medical conditions preventing informed consent (e.g., severe cognitive impairment).
About Heart Force Medical Inc.
Heart Force Medical Inc. is an innovative clinical trial sponsor dedicated to advancing cardiovascular health through cutting-edge medical technology and research. The company specializes in the development of non-invasive diagnostic and therapeutic solutions aimed at improving patient outcomes in heart disease. With a focus on rigorous scientific methodology and adherence to regulatory standards, Heart Force Medical Inc. collaborates with healthcare professionals and research institutions to conduct clinical trials that explore the efficacy and safety of its products. Committed to enhancing the quality of care in cardiology, the company seeks to transform the landscape of heart health through evidence-based advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tashkent, , Uzbekistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported